CI Falkson
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Bone health and treatments
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
- Cancer survivorship and care
Papers in
- Co-authors
- Justin L. Blackburn (1 shared paper)Tarun Arora (1 shared paper)Meredith L. Kilgore (1 shared paper)Victoria Chia (1 shared paper)Elizabeth Delzell (1 shared paper)Nalini Sathiakumar (1 shared paper)Michael A. Morrisey (1 shared paper)Thomas J. Smith (1 shared paper)
- Journals
- Cancer Research (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)Investigational New Drugs (1 paper)PubMed (3 papers)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
CI Falkson
6 papers receiving 2.1k citations
CI Falkson's Hit Papers
Peers
Comparison fields: 5 of 73
- Cancer Research 1.2k
- Oncology 453
- Genetics 338
- Pulmonary and Respiratory Medicine 190
- Family Practice 11
Countries citing papers authored by CI Falkson
This map shows the geographic impact of CI Falkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CI Falkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CI Falkson more than expected).
Fields of papers citing papers by CI Falkson
This network shows the impact of papers produced by CI Falkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CI Falkson. The network helps show where CI Falkson may publish in the future.
Co-authors
The 25 scholars most cited alongside CI Falkson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Hit paper breakdown → | 1998 | 1908 |
| 2 | 2011 | 182 | |
| 3 | 1992 | 27 | |
| 4 | Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93). | 2001 | 20 |
| 5 | 2011 | 14 | |
| 6 | A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia. | 1996 | 2 |
About CI Falkson
CI Falkson is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Reproductive Medicine and Cancer Research, having authored 6 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bone health and treatments (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Breast Cancer Treatment Studies (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Occupational and environmental lung diseases (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (453 citations), Genetics (338 citations), Pulmonary and Respiratory Medicine (190 citations) and Family Practice (11 citations). CI Falkson has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Justin L. Blackburn, Tarun Arora, Meredith L. Kilgore, Victoria Chia, Elizabeth Delzell, Nalini Sathiakumar, Michael A. Morrisey, Thomas J. Smith, Myla Hunt and John A. Hayes. Their work appears in journals such as Cancer Research, Prostate Cancer and Prostatic Diseases, Investigational New Drugs and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.